Literature DB >> 31499472

2D J-correlated proton NMR experiments for structural fingerprinting of biotherapeutics.

Robert G Brinson1, John P Marino2.   

Abstract

The higher order structure (HOS) of protein therapeutics is essential for drug safety and efficacy and can be evaluated by two-dimensional (2D) nuclear magnetic resonance (NMR) spectroscopy at atomic resolution. 1Hn-15N amide correlated and 1H-13C methyl correlated NMR spectroscopies at natural isotopic abundance have been demonstrated as feasible on protein therapeutics as large as monoclonal antibodies and show great promise for use in establishing drug substance structural consistency across manufacturing changes and in comparing a biosimilar to an originator reference product. Spectral fingerprints from 1Hn-1Hα correlations acquired using 2D homonuclear proton-proton J-correlated NMR experiments provide a complementary approach for high-resolution assessment of the HOS of lower molecular weight (<25 kDa) protein therapeutics. Here, we evaluate different pulse sequences (COSY, TOCSY and TACSY) used to generate proton-proton J-correlated NMR spectral fingerprints and appraise the performance of each method for application to protein therapeutic HOS assessment and comparability. Published by Elsevier Inc.

Entities:  

Keywords:  2D NMR; Biologic; COIN-TACSY; COSY; Fingerprinting; Higher order structure; TOCSY

Mesh:

Substances:

Year:  2019        PMID: 31499472      PMCID: PMC7313657          DOI: 10.1016/j.jmr.2019.106581

Source DB:  PubMed          Journal:  J Magn Reson        ISSN: 1090-7807            Impact factor:   2.229


  31 in total

1.  Profiling formulated monoclonal antibodies by (1)H NMR spectroscopy.

Authors:  Leszek Poppe; John B Jordan; Ken Lawson; Matthew Jerums; Izydor Apostol; Paul D Schnier
Journal:  Anal Chem       Date:  2013-09-24       Impact factor: 6.986

2.  Assessment of higher order structure comparability in therapeutic proteins using nuclear magnetic resonance spectroscopy.

Authors:  Carlos A Amezcua; Christina M Szabo
Journal:  J Pharm Sci       Date:  2013-04-09       Impact factor: 3.534

3.  Heteronuclear NMR as a 4-in-1 analytical platform for detecting modification-specific signatures of therapeutic insulin formulations.

Authors:  Xing Jin; Sunmi Kang; Hyuknam Kwon; Sunghyouk Park
Journal:  Anal Chem       Date:  2014-02-05       Impact factor: 6.986

4.  CLIP-COSY: A Clean In-Phase Experiment for the Rapid Acquisition of COSY-type Correlations.

Authors:  Martin R M Koos; Grit Kummerlöwe; Lukas Kaltschnee; Christina M Thiele; Burkhard Luy
Journal:  Angew Chem Int Ed Engl       Date:  2016-05-19       Impact factor: 15.336

5.  Effect of Polysorbate 20 and Polysorbate 80 on the Higher-Order Structure of a Monoclonal Antibody and Its Fab and Fc Fragments Probed Using 2D Nuclear Magnetic Resonance Spectroscopy.

Authors:  Surinder M Singh; Swati Bandi; David N M Jones; Krishna M G Mallela
Journal:  J Pharm Sci       Date:  2017-08-24       Impact factor: 3.534

6.  Assessment of the structure of pegylated-recombinant protein therapeutics by the NMR fingerprint assay.

Authors:  Derek J Hodgson; Yves Aubin
Journal:  J Pharm Biomed Anal       Date:  2017-02-16       Impact factor: 3.935

7.  Application of Natural Isotopic Abundance ¹H-¹³C- and ¹H-¹⁵N-Correlated Two-Dimensional NMR for Evaluation of the Structure of Protein Therapeutics.

Authors:  Luke W Arbogast; Robert G Brinson; John P Marino
Journal:  Methods Enzymol       Date:  2015-11-02       Impact factor: 1.600

8.  Non-Uniform Sampling for All: More NMR Spectral Quality, Less Measurement Time.

Authors:  Frank Delaglio; Gregory S Walker; Kathleen A Farley; Raman Sharma; Jeffrey C Hoch; Luke W Arbogast; Robert G Brinson; John P Marino
Journal:  Am Pharm Rev       Date:  2017-06-30

9.  Assessment of the higher order structure of Humira®, Remicade®, Avastin®, Rituxan®, Herceptin®, and Enbrel® by 2D-NMR fingerprinting.

Authors:  Derek J Hodgson; Houman Ghasriani; Yves Aubin
Journal:  J Pharm Biomed Anal       Date:  2018-10-01       Impact factor: 3.935

10.  Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.

Authors:  Robert G Brinson; John P Marino; Frank Delaglio; Luke W Arbogast; Ryan M Evans; Anthony Kearsley; Geneviève Gingras; Houman Ghasriani; Yves Aubin; Gregory K Pierens; Xinying Jia; Mehdi Mobli; Hamish G Grant; David W Keizer; Kristian Schweimer; Jonas Ståhle; Göran Widmalm; Edward R Zartler; Chad W Lawrence; Patrick N Reardon; John R Cort; Ping Xu; Feng Ni; Saeko Yanaka; Koichi Kato; Stuart R Parnham; Desiree Tsao; Andreas Blomgren; Torgny Rundlöf; Nils Trieloff; Peter Schmieder; Alfred Ross; Ken Skidmore; Kang Chen; David Keire; Darón I Freedberg; Thea Suter-Stahel; Gerhard Wider; Gregor Ilc; Janez Plavec; Scott A Bradley; Donna M Baldisseri; Mauricio Luis Sforça; Ana Carolina de Mattos Zeri; Julie Yu Wei; Christina M Szabo; Carlos A Amezcua; John B Jordan; Mats Wikström
Journal:  MAbs       Date:  2018-12-22       Impact factor: 5.857

View more
  4 in total

1.  Structural Fingerprinting of siRNA Therapeutics by Solution NMR Spectroscopy.

Authors:  Owen B Becette; Anh Tran; Jace W Jones; John P Marino; Robert G Brinson
Journal:  Nucleic Acid Ther       Date:  2022-03-09       Impact factor: 4.244

2.  Comparative Analysis of One-Dimensional Protein Fingerprint by Line Shape Enhancement and Two-Dimensional 1H,13C Methyl NMR Methods for Characterization of the Higher Order Structure of IgG1 Monoclonal Antibodies.

Authors:  Korth W Elliott; Houman Ghasriani; Mats Wikström; John P Giddens; Yves Aubin; Frank Delaglio; John P Marino; Luke W Arbogast
Journal:  Anal Chem       Date:  2020-04-14       Impact factor: 6.986

3.  Assessment of the Higher-Order Structure of Formulated Monoclonal Antibody Therapeutics by 2D Methyl Correlated NMR and Principal Component Analysis.

Authors:  Luke W Arbogast; Frank Delaglio; Robert G Brinson; John P Marino
Journal:  Curr Protoc Protein Sci       Date:  2020-06

Review 4.  Analytical Similarity Assessment of Biosimilars: Global Regulatory Landscape, Recent Studies and Major Advancements in Orthogonal Platforms.

Authors:  Neh Nupur; Srishti Joshi; Davy Gulliarme; Anurag S Rathore
Journal:  Front Bioeng Biotechnol       Date:  2022-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.